Melanie Marshall
Technik-/Wissenschafts-/F&E-Leiter bei OSSDSIGN AB
Profil
Melanie Marshall is currently working as the Vice President-Clinical & Medical Affairs at OssDsign AB since 2022.
Prior to this, she worked as the Vice President-Clinical Operations at ApaTech Ltd.
Ms. Marshall completed her undergraduate degree from Wheaton College (Massachusetts).
Aktive Positionen von Melanie Marshall
| Unternehmen | Position | Beginn |
|---|---|---|
| OSSDSIGN AB | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 |
Ehemalige bekannte Positionen von Melanie Marshall
| Unternehmen | Position | Ende |
|---|---|---|
ApaTech Ltd.
 ApaTech Ltd. Medical SpecialtiesHealth Technology ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Melanie Marshall
| Wheaton College (Massachusetts) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OSSDSIGN AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
ApaTech Ltd.
ApaTech Ltd. Medical SpecialtiesHealth Technology ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK. | Health Technology |
